In addition, samples of pediatric and adult T-ALL cases, particularly those with an ETP-ALL phenotype, collected from patients enrolled on a Clinical Oncology Group (COG) clinical trial, displayed Bcl-2 dependence [118]. This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.